Here is the latest stock price and chart of SAROJA PHARMA INDUSTRIES INDIA LTD.. For more details, see the SAROJA PHARMA INDUSTRIES INDIA LTD. company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Alert: Last Day to Access Our Research on Top 2 Bluechip Stocks
Live BSE Quotes |
---|
Not listed |
Live NSE Quotes | May 9, 2024 10:03:58 AM | ||
---|---|---|---|
Price (Rs)45.50 | Open (Rs) 0.00 | High (Rs) 0.00 | Low (Rs) 0.00 |
% Change0.00 | Volume 0 | Value (Rs) 0 | 52-Week H/L 82.90 / 35.00 |
BSE Sensex | CNX Nifty |
SAROJA PHARMA INDUSTRIES INDIA LTD. last traded price was up 0.0% to Rs 45.5 on the NSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.5%. And the benchmark NIFTY 50 was at 22,200.0 (down 0.5%).
As of March 2024, company promoters held 73.02% stake in SAROJA PHARMA INDUSTRIES INDIA LTD., with no shares having been pledged. To know more, check out the latest shareholding pattern of SAROJA PHARMA INDUSTRIES INDIA LTD..
On the NSE, SAROJA PHARMA INDUSTRIES INDIA LTD. last traded price was up 0.0% at Rs 45.5.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
Asian share markets are mixed today as investors awaited China trade data to gauge the health of the Chinese economy.